Pixelgen Technologies develops Molecular Pixelation (MPX) technology for high-resolution spatial proteomics, enabling detailed mapping of cell surface proteins in three dimensions. This technology provides critical insights into immune cell behavior and disease mechanisms, facilitating the development of personalized treatments and diagnostics.
Funding
$9.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.


Founders
Product
Problem
Traditional methods for analyzing cell surface proteins lack the resolution to capture the spatial context and interactions crucial for understanding cell behavior and disease mechanisms. Existing techniques often require specialized microscopy, are limited in multiplexing capability, and can be cumbersome to integrate into standard laboratory workflows.
Solution
Pixelgen Technologies offers Molecular Pixelation (MPX), a spatial proteomics technology that enables high-resolution mapping of cell surface proteins in three dimensions. The MPX platform utilizes DNA-tagged monoclonal antibodies to achieve unprecedented spatial protein multiplexing without the need for specialized microscopy. This approach provides detailed insights into protein co-localization and spatial relationships on the cell surface, offering a deeper understanding of cell biology, disease mechanisms, and drug mode of action. The resulting data can be integrated into existing NGS workflows, providing a scalable solution for cell and molecular biology laboratories.
Target Audience
The primary audience includes researchers and scientists in cell biology, immunology, and drug discovery who seek to gain a deeper understanding of cell surface protein interactions and their role in disease.
Features
- 3D Spatial Single Cell Proteomics: Molecular Pixelation (MPX) enables highly resolved cell surface protein maps for deep phenotyping of immune cells.
- Unprecedented Spatial Protein Multiplexing: DNA tagged monoclonal antibodies ensure high multiplex analysis of cell surface proteins with validated target specificity.
- In Focus Without a Microscope: Partitioning-free sample preparation provides spatially resolved abundance data similar to Confocal and Flow Cytometry, always in focus and from every angle.
- Leverage Existing NGS Workflow: Obtain single cell protein abundance, polarization and co-localization data with a simple, scalable solution.
- Validated target specificity: Ensures accurate and reliable protein detection.
- Smooth transition from analog to digital data readout: Simplifies data analysis and interpretation.